Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Journal of Qazvin University of Medical Sciences [The]. 2011; 15 (2): 28-33
Dans Persan | IMEMR | ID: emr-110439

Résumé

Identification of factors preventing preeclampsia in high risk pregnant women is of prime importance. The omega-3 supplementation may reduce the risk of preeclampsia. The aim of the present study was to assess the effects of omega-3 supplementation on high risk pregnancy for preeclampsia in the city of Qazvin. This was a single-blind randomized clinical trial conducted on 100 high risk pregnant women for preeclampsia over a period between 14 to 18 weeks of gestation in the city of Qazvin, Iran. Fifty patients were assigned to omega-3 group and another 50 to placebo group. Women were given a daily supplementation of 1000mg omega-3 or placebo until delivery. Later, preeclampsia and pregnancy outcome were assessed in both groups. Data were analyzed statistically using t-test, chi square test, Mannwhitney, and Fisher exact tests. There were significant differences between the omega-3 and placebo groups regarding the rate [p=0.015] and intensity [p=0.01] of preeclampsia. Statistically, a significant correlation between the omega-3 group and outcome of pregnancy including the birth weight [p=0.000] and apgar score [p=0.002] was found. Our results suggest that supplementation with omega-3 during pregnancy reduces the risk of preeclampsia in high risk pregnant women. Thus it seems necessary to promote educational programs on nutrition for pregnant women


Sujets)
Humains , Femelle , Pré-éclampsie/prévention et contrôle , Grossesse à haut risque , Méthode en simple aveugle , Placebo , Grossesse
SÉLECTION CITATIONS
Détails de la recherche